Global Hemophilia Gene Therapy Market Insights, Forecast to 2029
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemophilia Gene Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Hemophilia A
1.2.3 Hemophilia B
1.3 Market by Application
1.3.1 Global Hemophilia Gene Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hemophilia A Gene Therapy
1.3.3 Hemophilia B Gene Therapy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hemophilia Gene Therapy Market Perspective (2018-2029)
2.2 Global Hemophilia Gene Therapy Growth Trends by Region
2.2.1 Hemophilia Gene Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Hemophilia Gene Therapy Historic Market Size by Region (2018-2023)
2.2.3 Hemophilia Gene Therapy Forecasted Market Size by Region (2024-2029)
2.3 Hemophilia Gene Therapy Market Dynamics
2.3.1 Hemophilia Gene Therapy Industry Trends
2.3.2 Hemophilia Gene Therapy Market Drivers
2.3.3 Hemophilia Gene Therapy Market Challenges
2.3.4 Hemophilia Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Hemophilia Gene Therapy by Players
3.1.1 Global Hemophilia Gene Therapy Revenue by Players (2018-2023)
3.1.2 Global Hemophilia Gene Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Hemophilia Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Hemophilia Gene Therapy, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Hemophilia Gene Therapy Market Concentration Ratio
3.4.1 Global Hemophilia Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemophilia Gene Therapy Revenue in 2022
3.5 Global Key Players of Hemophilia Gene Therapy Head office and Area Served
3.6 Global Key Players of Hemophilia Gene Therapy, Product and Application
3.7 Global Key Players of Hemophilia Gene Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hemophilia Gene Therapy Breakdown Data by Type
4.1 Global Hemophilia Gene Therapy Historic Market Size by Type (2018-2023)
4.2 Global Hemophilia Gene Therapy Forecasted Market Size by Type (2024-2029)
5 Hemophilia Gene Therapy Breakdown Data by Application
5.1 Global Hemophilia Gene Therapy Historic Market Size by Application (2018-2023)
5.2 Global Hemophilia Gene Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Hemophilia Gene Therapy Market Size (2018-2029)
6.2 North America Hemophilia Gene Therapy Market Size by Type
6.2.1 North America Hemophilia Gene Therapy Market Size by Type (2018-2023)
6.2.2 North America Hemophilia Gene Therapy Market Size by Type (2024-2029)
6.2.3 North America Hemophilia Gene Therapy Market Share by Type (2018-2029)
6.3 North America Hemophilia Gene Therapy Market Size by Application
6.3.1 North America Hemophilia Gene Therapy Market Size by Application (2018-2023)
6.3.2 North America Hemophilia Gene Therapy Market Size by Application (2024-2029)
6.3.3 North America Hemophilia Gene Therapy Market Share by Application (2018-2029)
6.4 North America Hemophilia Gene Therapy Market Size by Country
6.4.1 North America Hemophilia Gene Therapy Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Hemophilia Gene Therapy Market Size by Country (2018-2023)
6.4.3 North America Hemophilia Gene Therapy Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Hemophilia Gene Therapy Market Size (2018-2029)
7.2 Europe Hemophilia Gene Therapy Market Size by Type
7.2.1 Europe Hemophilia Gene Therapy Market Size by Type (2018-2023)
7.2.2 Europe Hemophilia Gene Therapy Market Size by Type (2024-2029)
7.2.3 Europe Hemophilia Gene Therapy Market Share by Type (2018-2029)
7.3 Europe Hemophilia Gene Therapy Market Size by Application
7.3.1 Europe Hemophilia Gene Therapy Market Size by Application (2018-2023)
7.3.2 Europe Hemophilia Gene Therapy Market Size by Application (2024-2029)
7.3.3 Europe Hemophilia Gene Therapy Market Share by Application (2018-2029)
7.4 Europe Hemophilia Gene Therapy Market Size by Country
7.4.1 Europe Hemophilia Gene Therapy Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Hemophilia Gene Therapy Market Size by Country (2018-2023)
7.4.3 Europe Hemophilia Gene Therapy Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Hemophilia Gene Therapy Market Size (2018-2029)
8.2 China Hemophilia Gene Therapy Market Size by Type
8.2.1 China Hemophilia Gene Therapy Market Size by Type (2018-2023)
8.2.2 China Hemophilia Gene Therapy Market Size by Type (2024-2029)
8.2.3 China Hemophilia Gene Therapy Market Share by Type (2018-2029)
8.3 China Hemophilia Gene Therapy Market Size by Application
8.3.1 China Hemophilia Gene Therapy Market Size by Application (2018-2023)
8.3.2 China Hemophilia Gene Therapy Market Size by Application (2024-2029)
8.3.3 China Hemophilia Gene Therapy Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Hemophilia Gene Therapy Market Size (2018-2029)
9.2 Asia Hemophilia Gene Therapy Market Size by Type
9.2.1 Asia Hemophilia Gene Therapy Market Size by Type (2018-2023)
9.2.2 Asia Hemophilia Gene Therapy Market Size by Type (2024-2029)
9.2.3 Asia Hemophilia Gene Therapy Market Share by Type (2018-2029)
9.3 Asia Hemophilia Gene Therapy Market Size by Application
9.3.1 Asia Hemophilia Gene Therapy Market Size by Application (2018-2023)
9.3.2 Asia Hemophilia Gene Therapy Market Size by Application (2024-2029)
9.3.3 Asia Hemophilia Gene Therapy Market Share by Application (2018-2029)
9.4 Asia Hemophilia Gene Therapy Market Size by Region
9.4.1 Asia Hemophilia Gene Therapy Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Hemophilia Gene Therapy Market Size by Region (2018-2023)
9.4.3 Asia Hemophilia Gene Therapy Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Spark Therapeutics
11.1.1 Spark Therapeutics Company Details
11.1.2 Spark Therapeutics Business Overview
11.1.3 Spark Therapeutics Hemophilia Gene Therapy Introduction
11.1.4 Spark Therapeutics Revenue in Hemophilia Gene Therapy Business (2018-2023)
11.1.5 Spark Therapeutics Recent Developments
11.2 Ultragenyx
11.2.1 Ultragenyx Company Details
11.2.2 Ultragenyx Business Overview
11.2.3 Ultragenyx Hemophilia Gene Therapy Introduction
11.2.4 Ultragenyx Revenue in Hemophilia Gene Therapy Business (2018-2023)
11.2.5 Ultragenyx Recent Developments
11.3 Shire PLC
11.3.1 Shire PLC Company Details
11.3.2 Shire PLC Business Overview
11.3.3 Shire PLC Hemophilia Gene Therapy Introduction
11.3.4 Shire PLC Revenue in Hemophilia Gene Therapy Business (2018-2023)
11.3.5 Shire PLC Recent Developments
11.4 Sangamo Therapeutics
11.4.1 Sangamo Therapeutics Company Details
11.4.2 Sangamo Therapeutics Business Overview
11.4.3 Sangamo Therapeutics Hemophilia Gene Therapy Introduction
11.4.4 Sangamo Therapeutics Revenue in Hemophilia Gene Therapy Business (2018-2023)
11.4.5 Sangamo Therapeutics Recent Developments
11.5 Bioverativ
11.5.1 Bioverativ Company Details
11.5.2 Bioverativ Business Overview
11.5.3 Bioverativ Hemophilia Gene Therapy Introduction
11.5.4 Bioverativ Revenue in Hemophilia Gene Therapy Business (2018-2023)
11.5.5 Bioverativ Recent Developments
11.6 BioMarin
11.6.1 BioMarin Company Details
11.6.2 BioMarin Business Overview
11.6.3 BioMarin Hemophilia Gene Therapy Introduction
11.6.4 BioMarin Revenue in Hemophilia Gene Therapy Business (2018-2023)
11.6.5 BioMarin Recent Developments
11.7 uniQure
11.7.1 uniQure Company Details
11.7.2 uniQure Business Overview
11.7.3 uniQure Hemophilia Gene Therapy Introduction
11.7.4 uniQure Revenue in Hemophilia Gene Therapy Business (2018-2023)
11.7.5 uniQure Recent Developments
11.8 Freeline Therapeutics
11.8.1 Freeline Therapeutics Company Details
11.8.2 Freeline Therapeutics Business Overview
11.8.3 Freeline Therapeutics Hemophilia Gene Therapy Introduction
11.8.4 Freeline Therapeutics Revenue in Hemophilia Gene Therapy Business (2018-2023)
11.8.5 Freeline Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Hemophilia Gene Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Hemophilia A
Table 3. Key Players of Hemophilia B
Table 4. Global Hemophilia Gene Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Hemophilia Gene Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Hemophilia Gene Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Hemophilia Gene Therapy Market Share by Region (2018-2023)
Table 8. Global Hemophilia Gene Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Hemophilia Gene Therapy Market Share by Region (2024-2029)
Table 10. Hemophilia Gene Therapy Market Trends
Table 11. Hemophilia Gene Therapy Market Drivers
Table 12. Hemophilia Gene Therapy Market Challenges
Table 13. Hemophilia Gene Therapy Market Restraints
Table 14. Global Hemophilia Gene Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Hemophilia Gene Therapy Revenue Share by Players (2018-2023)
Table 16. Global Top Hemophilia Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia Gene Therapy as of 2022)
Table 17. Global Hemophilia Gene Therapy Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Hemophilia Gene Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Hemophilia Gene Therapy, Headquarters and Area Served
Table 20. Global Key Players of Hemophilia Gene Therapy, Product and Application
Table 21. Global Key Players of Hemophilia Gene Therapy, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hemophilia Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Hemophilia Gene Therapy Revenue Market Share by Type (2018-2023)
Table 25. Global Hemophilia Gene Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Hemophilia Gene Therapy Revenue Market Share by Type (2024-2029)
Table 27. Global Hemophilia Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Hemophilia Gene Therapy Revenue Share by Application (2018-2023)
Table 29. Global Hemophilia Gene Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Hemophilia Gene Therapy Revenue Share by Application (2024-2029)
Table 31. North America Hemophilia Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Hemophilia Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Hemophilia Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Hemophilia Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Hemophilia Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Hemophilia Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Hemophilia Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Hemophilia Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Hemophilia Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Hemophilia Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Hemophilia Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Hemophilia Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Hemophilia Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Hemophilia Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Hemophilia Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Hemophilia Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Hemophilia Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Hemophilia Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Hemophilia Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Hemophilia Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Hemophilia Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Hemophilia Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Hemophilia Gene Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Hemophilia Gene Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Hemophilia Gene Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Hemophilia Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 63. Spark Therapeutics Company Details
Table 64. Spark Therapeutics Business Overview
Table 65. Spark Therapeutics Hemophilia Gene Therapy Product
Table 66. Spark Therapeutics Revenue in Hemophilia Gene Therapy Business (2018-2023) & (US$ Million)
Table 67. Spark Therapeutics Recent Developments
Table 68. Ultragenyx Company Details
Table 69. Ultragenyx Business Overview
Table 70. Ultragenyx Hemophilia Gene Therapy Product
Table 71. Ultragenyx Revenue in Hemophilia Gene Therapy Business (2018-2023) & (US$ Million)
Table 72. Ultragenyx Recent Developments
Table 73. Shire PLC Company Details
Table 74. Shire PLC Business Overview
Table 75. Shire PLC Hemophilia Gene Therapy Product
Table 76. Shire PLC Revenue in Hemophilia Gene Therapy Business (2018-2023) & (US$ Million)
Table 77. Shire PLC Recent Developments
Table 78. Sangamo Therapeutics Company Details
Table 79. Sangamo Therapeutics Business Overview
Table 80. Sangamo Therapeutics Hemophilia Gene Therapy Product
Table 81. Sangamo Therapeutics Revenue in Hemophilia Gene Therapy Business (2018-2023) & (US$ Million)
Table 82. Sangamo Therapeutics Recent Developments
Table 83. Bioverativ Company Details
Table 84. Bioverativ Business Overview
Table 85. Bioverativ Hemophilia Gene Therapy Product
Table 86. Bioverativ Revenue in Hemophilia Gene Therapy Business (2018-2023) & (US$ Million)
Table 87. Bioverativ Recent Developments
Table 88. BioMarin Company Details
Table 89. BioMarin Business Overview
Table 90. BioMarin Hemophilia Gene Therapy Product
Table 91. BioMarin Revenue in Hemophilia Gene Therapy Business (2018-2023) & (US$ Million)
Table 92. BioMarin Recent Developments
Table 93. uniQure Company Details
Table 94. uniQure Business Overview
Table 95. uniQure Hemophilia Gene Therapy Product
Table 96. uniQure Revenue in Hemophilia Gene Therapy Business (2018-2023) & (US$ Million)
Table 97. uniQure Recent Developments
Table 98. Freeline Therapeutics Company Details
Table 99. Freeline Therapeutics Business Overview
Table 100. Freeline Therapeutics Hemophilia Gene Therapy Product
Table 101. Freeline Therapeutics Revenue in Hemophilia Gene Therapy Business (2018-2023) & (US$ Million)
Table 102. Freeline Therapeutics Recent Developments
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Hemophilia Gene Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Hemophilia Gene Therapy Market Share by Type: 2022 VS 2029
Figure 3. Hemophilia A Features
Figure 4. Hemophilia B Features
Figure 5. Global Hemophilia Gene Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Hemophilia Gene Therapy Market Share by Application: 2022 VS 2029
Figure 7. Hemophilia A Gene Therapy Case Studies
Figure 8. Hemophilia B Gene Therapy Case Studies
Figure 9. Hemophilia Gene Therapy Report Years Considered
Figure 10. Global Hemophilia Gene Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Hemophilia Gene Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Hemophilia Gene Therapy Market Share by Region: 2022 VS 2029
Figure 13. Global Hemophilia Gene Therapy Market Share by Players in 2022
Figure 14. Global Top Hemophilia Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia Gene Therapy as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Hemophilia Gene Therapy Revenue in 2022
Figure 16. North America Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Hemophilia Gene Therapy Market Share by Type (2018-2029)
Figure 18. North America Hemophilia Gene Therapy Market Share by Application (2018-2029)
Figure 19. North America Hemophilia Gene Therapy Market Share by Country (2018-2029)
Figure 20. United States Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Hemophilia Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 23. Europe Hemophilia Gene Therapy Market Share by Type (2018-2029)
Figure 24. Europe Hemophilia Gene Therapy Market Share by Application (2018-2029)
Figure 25. Europe Hemophilia Gene Therapy Market Share by Country (2018-2029)
Figure 26. Germany Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. China Hemophilia Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 33. China Hemophilia Gene Therapy Market Share by Type (2018-2029)
Figure 34. China Hemophilia Gene Therapy Market Share by Application (2018-2029)
Figure 35. Asia Hemophilia Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 36. Asia Hemophilia Gene Therapy Market Share by Type (2018-2029)
Figure 37. Asia Hemophilia Gene Therapy Market Share by Application (2018-2029)
Figure 38. Asia Hemophilia Gene Therapy Market Share by Region (2018-2029)
Figure 39. Japan Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. South Korea Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. China Taiwan Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Southeast Asia Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. India Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Australia Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Share by Type (2018-2029)
Figure 47. Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Share by Application (2018-2029)
Figure 48. Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Share by Country (2018-2029)
Figure 49. Brazil Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Mexico Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Turkey Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Israel Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. GCC Countries Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Spark Therapeutics Revenue Growth Rate in Hemophilia Gene Therapy Business (2018-2023)
Figure 56. Ultragenyx Revenue Growth Rate in Hemophilia Gene Therapy Business (2018-2023)
Figure 57. Shire PLC Revenue Growth Rate in Hemophilia Gene Therapy Business (2018-2023)
Figure 58. Sangamo Therapeutics Revenue Growth Rate in Hemophilia Gene Therapy Business (2018-2023)
Figure 59. Bioverativ Revenue Growth Rate in Hemophilia Gene Therapy Business (2018-2023)
Figure 60. BioMarin Revenue Growth Rate in Hemophilia Gene Therapy Business (2018-2023)
Figure 61. uniQure Revenue Growth Rate in Hemophilia Gene Therapy Business (2018-2023)
Figure 62. Freeline Therapeutics Revenue Growth Rate in Hemophilia Gene Therapy Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed